Rethinking Cancer Naming: The Case for Genetic-Based Classification
TL;DR Summary
Fabrice André, a medical oncologist, advocates for a new cancer naming system that focuses on the molecular characteristics of tumors rather than their tissue of origin, as genetic alterations can drive cancer growth and treatment responses. This approach could lead to faster access to targeted therapies and benefit patients with rare cancers, as well as improve patient understanding and engagement with their treatment.
- Time to name cancers by genetics, not organ of origin, expert says STAT
- Forget lung, breast or prostate cancer: why tumour naming needs to change Nature.com
- The Cancer That Doctors Don't Want to Call Cancer The Wall Street Journal
- The Morning Rush - Medical Myth Busting with Dr. Barry Dworkin iHeartRadio Canada
- How cancers are NAMED 'needs to change', say doctors who warn that labelling tumours after breast, lung and other organs is denting survival rates MSN
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
5 min
vs 6 min read
Condensed
94%
1,082 → 63 words
Want the full story? Read the original article
Read on STAT